Meiji Yasuda Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-64,492
Closed -$899K 610
2023
Q3
$899K Sell
64,492
-617
-0.9% -$7.89K 0.04% 340
2023
Q2
$766K Hold
65,109
0.04% 327
2023
Q1
$749K Hold
65,109
0.04% 330
2022
Q4
$809 Hold
65,109
0.04% 346
2022
Q3
$854K Buy
65,109
+417
+0.6% +$6.16K 0.05% 326
2022
Q2
$904K Buy
64,692
+24,630
+61% +$329K 0.05% 341
2022
Q1
$597K Buy
+40,062
New +$548K 0.03% 420

Other funds holding SBRA

Meiji Yasuda Asset Management's SBRA Position: Q4 2023 in Review

Meiji Yasuda Asset Management sold out of Sabra Healthcare REIT (SBRA) in Q4 2023, closing a stake of 64,492 shares — an estimated $899K sold.

Meiji Yasuda Asset Management first reported a position in SBRA in Q1 2022 and held it in 7 quarters. The position peaked at $904K in Q2 2022. 359 funds tracked by Wall St. Rank hold SBRA as of Q4 2023.

  • Meiji Yasuda Asset Management reported no remaining Sabra Healthcare REIT position as of Q4 2023 after selling out during the quarter.
  • Meiji Yasuda Asset Management sold 64,492 Sabra Healthcare REIT shares in Q4 2023, an estimated $899K.
  • Meiji Yasuda Asset Management first reported a position in Sabra Healthcare REIT in Q1 2022 and held it in 7 quarters.
  • Meiji Yasuda Asset Management's Sabra Healthcare REIT position peaked at $904K in Q2 2022.
  • 359 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2023.

Based on Meiji Yasuda Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.